semaglutide granite bay GLP-1 Medical Weight Loss Specialist in Folsom, CA SEMAGLUTIDE & TIRZEPATIDE for Weight

Additionally, the FDA labeling for semaglutide includes specific guidance regarding pregnancy, which has contributed to patient concerns about broader reproductive health implications

Could Semaglutide Ever Cause a False Positive

However, some symptoms may require medical attention

But other doctors say more long-term data is needed before committing patients to this drug for life

The US Food and Drug Administration (FDA) accepted Novo Nordisks (NOV: N) New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established cardiovascular disease